AbClon Inc. (KOSDAQ:174900)
19,220
-240 (-1.23%)
Sep 22, 2026, 3:30 PM KST
AbClon Market Cap
AbClon has a market cap or net worth of 388.27 billion as of September 22, 2026. Its market cap has increased by 46.51% in one year.
Market Cap
388.27B
Enterprise Value
359.63B
Revenue
5.31B
Ranking
n/a
PE Ratio
n/a
Stock Price
19,220.00
ChartMarket Cap Chart
Since September 18, 2017, AbClon's market cap has increased from 176.80B to 388.27B, an increase of 119.61%. That is a compound annual growth rate of 9.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 388.27B | -52.20% |
| Dec 30, 2025 | 812.27B | 230.14% |
| Dec 30, 2024 | 246.04B | 6.90% |
| Dec 28, 2023 | 230.16B | 17.39% |
| Dec 29, 2022 | 196.07B | -27.49% |
| Dec 30, 2021 | 270.42B | -48.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Onconic Therapeutics | 674.76B |
| Hyundai Bioscience | 656.22B |
| GI Innovation | 616.77B |
| Medy-Tox | 434.64B |
| GC Corp. | 433.96B |
| Proteina | 386.78B |
| MEDIPOST | 346.69B |
| SillaJen | 305.51B |